Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Removed Melanoma from the page's additional MeSH terms and deleted the Related topics heading and MedlinePlus Genetics reference, altering how the study is categorized and linked to genetics resources.
    Difference
    0.1%
    Check dated 2026-05-01T20:18:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s footer/module metadata was updated to reflect new related-topic listings (MedlinePlus/Genetics) and a site revision version, with no change to the underlying study record content.
    Difference
    0.2%
    Check dated 2026-04-24T16:46:04.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:39:18.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed related topic links 'Melanoma' and 'MedlinePlus Genetics' from the page's related topics section.
    Difference
    0.1%
    Check dated 2026-04-10T08:54:00.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the study page.
    Difference
    0.1%
    Check dated 2026-04-03T05:29:57.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Removed the melanoma keyword tag and the related topics MedlinePlus Genetics from the study page’s terms.
    Difference
    0.1%
    Check dated 2026-03-27T01:31:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.